TIME TO DISCONTINUATION AND EFFECTIVENESS OF BARICITINIB IN RHEUMATOID ARTHRITIS: 12-MONTH EUROPEAN DATA FROM A MULTINATIONAL, PROSPECTIVE, OBSERVATIONAL STUDY

被引：0
|
作者：
Alten, Rieke [1 ]
Burmester, Gerd R. [2 ]
Matucci-Cerinic, Marco [3 ,4 ]
Ostor, Andrew [5 ]
Zaremba-Pechmann, Liliana [6 ]
Treuer, Tamas [7 ]
Ng, Khai Jing [7 ]
Gerwien, Jens [7 ]
Gibson, Kathryn A. [7 ]
Fautrel, Bruno [8 ,9 ]
Pile, Kevin [10 ]
机构：
[1] Univ Med Berlin, Dept Internal Med & Rheumatol, Schlossprk Klin, Berlin, Germany
[2] Charite Univ Med Berlin, Dept Rheumatol & Clin Immunol, Berlin, Germany
[3] Univ Florence, Div Rheumatol, Florence, Italy
[4] IRCCS San Raffaele Hosp, Unit Immunol Rheumatol Allergy & Rare Dis UnIRAR, Milan, Italy
[5] Monash Univ, Cabrini Hosp, Melbourne, Australia
[6] HaaPACS GmbH, Schriesheim, Germany
[7] Eli Lilly & Co, Indianapolis, IN 46285 USA
[8] Sorbonne Univ, Assistance Publ Hop Paris, Pitie Salpetriere Hosp, Dept Rheumatol, Paris, France
[9] Pierre Louis Inst Epidemiol & Publ Hlth, PEPITES team, Paris, France
[10] Western Sydney Univ, Sydney, Australia
来源：
INTERNAL MEDICINE JOURNAL | 2023年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
ARA-P67
引用
下载
收藏
页码：36 / 37
页数：2
相关论文
共 50 条
  • [1] TIME TO DISCONTINUATION AND EFFECTIVENESS WITH BARICITINIB IN RHEUMATOID ARTHRITIS: 12-MONTH EUROPEAN DATA FROM A MULTINATIONAL, PROSPECTIVE, OBSERVATIONAL STUDY
    Alten, Rieke
    Burmester, Gerd R.
    Matucci-Cerinic, Marco
    Ostor, Andrew
    Zaremba-Pechmann, Liliana
    Treuer, Tamas
    Ng, Khai Jing
    Gerwien, Jens
    Gibson, Kathryn A.
    Fautrel, Bruno
    Sheeran, Thomas
    RHEUMATOLOGY, 2023, 62
  • [2] Time to Discontinuation and Effectiveness of Baricitinib in Rheumatoid Arthritis: 12-Month European Data from a Multinational, Prospective, Observational Study
    Alten, R.
    Burmester, G.
    Matucci-Cerinic, M.
    Ostor, A.
    Zaremba-Pechmann, L.
    Treuer, T.
    Ng, K.
    Gerwien, J.
    Gibson, K.
    Fautrel, B.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2023, 52 : 60 - 61
  • [3] Time to Discontinuation and Effectiveness with Baricitinib in Rheumatoid Arthritis: 12-Month European Data from a Multinational, Prospective, Observational Study
    Alten, Rieke
    Burmester, Gerd
    Matucci-Cerinic, Marco
    Ostor, Andrew
    Zaremba-Pechmann, Liliana
    Treuer, Tamas
    Ng, Khai Jing
    Gerwien, Jens
    Gibson, Kathryn
    Fautrel, Bruno
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2796 - 2798
  • [4] A MULTINATIONAL, PROSPECTIVE, OBSERVATIONAL STUDY IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING BARICITINIB, TARGETED SYNTHETIC OR BIOLOGIC DISEASE-MODIFYING THERAPIES: 12 MONTH TIME TO DISCONTINUATION, EFFECTIVENESS AND PATIENT REPORTED OUTCOME DATA FROM THE EUROPEAN COHORT
    Alten, R.
    Burmester, G. R.
    Cerinic, M. Matucci
    Ostor, A.
    Zaremba-Pechmann, L.
    Herrera, M.
    Gibson, K.
    Treuer, T.
    Gerwien, J.
    Fautrel, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 606 - 607
  • [5] Comparative Effectiveness, Time to Discontinuation, and Patient-Reported Outcomes with Baricitinib in Rheumatoid Arthritis: 2-Year Data from the Multinational, Prospective Observational RA-BE-REAL Study in European Patients
    Alten, Rieke
    Burmester, Gerd R.
    Matucci-Cerinic, Marco
    Salmon, Jean-Hugues
    Ostor, Andrew
    Ng, Khai Jing
    Gerwien, Jens
    Zaremba-Pechmann, Liliana
    Brnabic, Alan J. M.
    Fautrel, Bruno
    RHEUMATOLOGY AND THERAPY, 2023, 10 (06) : 1575 - 1595
  • [6] Comparative Effectiveness, Time to Discontinuation, and Patient-Reported Outcomes with Baricitinib in Rheumatoid Arthritis: 2-Year Data from the Multinational, Prospective Observational RA-BE-REAL Study in European Patients
    Rieke Alten
    Gerd R. Burmester
    Marco Matucci-Cerinic
    Jean-Hugues Salmon
    Andrew Östör
    Khai Jing Ng
    Jens Gerwien
    Liliana Zaremba-Pechmann
    Alan J. M. Brnabic
    Bruno Fautrel
    Rheumatology and Therapy, 2023, 10 : 1575 - 1595
  • [7] Healthcare Resource Use by European Patients Enrolled in RA-BE-REAL: 12 Month Data From a Multinational, Prospective, Observational Study of Patients With Rheumatoid Arthritis
    Alten, R.
    Burmester, G.
    Matucci-Cerinic, M.
    Ostor, A.
    Zaremba-Pechmann, L.
    Treuer, T.
    Ng, K. J.
    Gerwien, J.
    Gibson, K.
    Fautrel, B.
    VALUE IN HEALTH, 2022, 25 (12) : S461 - S461
  • [8] A Multinational, Prospective, Observational Study in Patients with Rheumatoid Arthritis Receiving Baricitinib, Targeted Synthetic or Biologic Disease-Modifying Therapies: 6-Month Effectiveness and Patient Reported Outcome Data from the European Cohort
    Burmester, Gerd
    Fautrel, Bruno
    Alten, Rieke
    Matucci-Cerinic, Marco
    Salmon, Jean Hugues
    Holzkaemper, Thorsten
    De la Torre, Inmaculada
    Lopez-Romero, Pedro
    Fakhouri, Walid
    Gentzel-Jorczyk, Anja
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 2522 - 2525
  • [9] A MULTINATIONAL, PROSPECTIVE, OBSERVATIONAL STUDY IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING BARICITINIB, TARGETED SYNTHETIC OR BIOLOGIC DISEASE-MODIFYING THERAPIES: 6-MONTH EFFECTIVENESS AND PATIENT-REPORTED OUTCOME DATA FROM THE EUROPEAN COHORT
    Kiprianos, Allan
    Alten, Rieke
    Burmester, Gerd
    Matucci-Cerinic, Marco
    Salmon, Jean-Hugues
    Lopez-Romero, Pedro
    Fakhouri, Walid
    de la Torre, Inmaculada
    Gentzel-Jorczyk, Anja
    Holzkamper, Thorsten
    Fautrel, Bruno
    RHEUMATOLOGY, 2022, 61 : I112 - +
  • [10] Lipid Profile after Pharmacologic Discontinuation and Restoration of Menstruation in Women with Endometriosis: A 12-Month Observational Prospective Study
    Anastasilakis, Athanasios D.
    Polyzos, Stergios A.
    Vorkas, Panagiotis A.
    Gkiomisi, Athina
    Yavropoulou, Maria P.
    Rauner, Martina
    Nikolakopoulos, Panagiotis
    Papachatzopoulos, Stergios
    Makras, Polyzois
    Gerou, Spyridon
    Hofbauer, Lorenz C.
    Palermo, Andrea
    Tsourdi, Elena
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (16)
12345